Reiner Laus

Reiner Laus has a diverse work experience in the pharmaceutical and biotechnology industry. Reiner is the Co-Founder and CEO of TRIO Pharmaceuticals, Inc. since April 2021. Prior to that, they served as the President & CEO of Annias Immunotherapeutics from April 2014 to October 2022. Reiner also held the position of President & CEO at Bolt Biotherapeutics, Inc. from May 2016 to January 2017. Before that, they were the President & CEO of BN ImmunoTherapeutics from January 2005 to March 2013.

Reiner Laus began their career in research and development, serving as the Vice President of Research & Development at Dendreon Corporation from 1993 to 2004. Reiner previously held a faculty position at the University of Kiel from 1986 to 1993. Additionally, they worked as a research fellow at Stanford University School of Medicine from 1989 to 1992.

Reiner Laus pursued their higher education at Kiel University, where they studied from 1979 to 1986. During this period, they obtained a Doctor of Medicine (MD) degree. The specific field of study that Reiner Laus focused on during their time at Kiel University is not provided.